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recombinant proteins via BEVS (Bédard et al., 1997; Chan et al., 1998; Chiou et al., 2000) . The 74 combination of metabolic flux analysis with the rational design of a feeding strategy improved 75 baculovirus yields (6-to 7-fold) in high cell density cultures (Carinhas et al., 2010) . Also, the 76 on-line monitoring of the oxygen uptake rate (OUR) in baculovirus infected insect cells 77 supported the design of feeding strategies able to boost up to 13 times the recombinant protein 78 yields (Palomares et al., 2004) . Overall, the successful application of metabolic and bioprocess 79 engineering strategies to the IC-BEVS shows that there is room for improvement. Also, it seems 80 clear that knowledge on key parameters of cellular physiology can help in devising such efforts 81 towards increased productivity. 82
Although progress has been made in tuning the baculovirus to accommodate the expression 83 of challenging targets (Bieniossek et al., 2012; Palmberger et al., 2013) , the accumulation of 84 defective interfering particles (DIF) with increasing viral passages constraints baculovirus-based 85 bioprocesses (Pijlman et al., 2001) . The loss of expression of heterologous gene(s) and low 86 infectivity of the baculovirus expression vector occurs as a consequence of recombination 87 events during viral replication (Pijlman et al., 2003) , and the impact of the heterologous gene(s) 88 on this event is not fully understood. 89
In previous works, metabolic pathways correlated with baculovirus infection and IC-BEVS 90 productivity were identified based on fluxome analysis (Bernal et al. 2009, Monteiro et al. in 91 preparation) and metabolomic fingerprinting (Monteiro et al. 2014) . Although several 92 metabolic differences were assessed between the two insect cell lines more used for protein and 93 virus production (Trichoplusia ni High Five and Spodoptera frugiperda Sf9 cells, respectively) 94 responses to infection were very similar (Monteiro et al. 2014) . 95
In the present work, we designed culture supplementation schemes aiming to boost IC-96 BEVS productivity and quality of complex enveloped viral particles: influenza VLPs (Inf-97 VLPs) and baculovirus (BV). Supplements selection was based on our previous identification of 98 the metabolic pathways correlated with IC-BEVS productivity (Monteiro et al., 2014) , with the 99 goal of enhancing pathway activity and systems performance. An orthogonal screening of 100 culture conditions was performed to pin-point the culture setting leading to maximal 101 productivity in Sf9 cells, addressing target specific key requirements. Finally, an optimized 102 bioprocess for the production of high quality enveloped viral particles via BEVS was 103 implemented. 104 (Corning, USA) with 50 mL working volume. Cultures were kept in a humidified incubator 111 operated at 90 rpm and 27ºC. Routinely, Sf9 cells were re-inoculated every 3-4 days at 0.45x10 6 112 cells.mL -1 . Cell concentration was determined by hemocytometer cell counts and viability 113 evaluated by the trypan blue exclusion method. 114
Baculoviruses and viral stock preparation 115
The recombinant Autographa californica nucleopolyhedrovirus BvHA5M1 was used 116 throughout the work as the expression vector of the enveloped influenza VLPs (Inf-VLPs). This 117 vector is a dual baculovirus, encoding two influenza genes: Hemagglutinin type 5 (H5), under 118 the control of the polyhedrin promoter, and matrix protein 1 (M1), under the control of the p10 119 promoter. 120
BvHA5M1 was amplified by infecting Sf9 cells at 1x10 6 cells.mL -1 with a multiplicity of 121 infection (MOI) of 0.01 IP.cell -1 in a 10 L bioreactor (ED10, Sartorius AG, Goettingen, 122 Germany). To generate a highly concentrated viral stock, a polyethylene glycol (PEG)-based 123 concentration process was applied. Briefly, virus-containing culture supernatant was mixed with 124 8.5% (v/v) of a sterile PEG solution prepared in phosphate buffer saline (PBS), and incubated 125 overnight at 4ºC. The mixture was centrifuged at 3200xg for 30 min at 4ºC, and the collected 126 pellet containing the baculovirus was suspended in 0.5 M sucrose. The concentrated viral stocks 127 were titrated, aliquoted and kept at -80ºC until further use. 128
Baculovirus titration and total particles quantification 129
Baculovirus infectious particles quantification was performed following the MTT assay, as 130 previously described in Roldão et al. (2009) . Baculovirus total particles concentration was 131 assessed by counting the baculovirus particles in a Nanosight NS500 (Nanosight Ltd., Salisbury, 132 UK), using the Nanoparticle Tracking Analysis (NTA) software. The average size of purified 133
Inf-VLPs samples and baculovirus was identified a priori for the determination of the gates for 134 both particles quantification (data not shown). To exclude minor errors due to counting of 135 cellular debris, exosomes, and other particles that can interfere with the accuracy of the 136 measurements, appropriate controls were performed (supernatant of non-infected cultures at the 137 correspondent cell densities). The measurements were performed at least in triplicates with a 138 typical standard deviation (SD) below 20%. 139
Supplements preparation 140
The culture supplements tested, listed in Table 1 , were selected as boosters of the metabolic 141 pathways correlated with IC-BEVS productivity. Supplements concentration was set taking into 142 account the manufacturer instructions and preliminary assays of their impact in the specific 143 productivity and viability of Sf9 cells (data not shown). Supplements were prepared in Sf900II 144 insect culture media (Gibco), and stored according to the manufacturer instructions. Cholesterol 145 supplementation was performed in combination with 0.4 mg.L -1 albumin (Merck Millipore,
Cell growth, infection and production studies 148
The experimental set-up is depicted in Figure 1 . To identify the impact of the 149 supplementation strategy on enveloped viral particles yields, an exploratory screening was 150 designed using the Advanced Microscale Bioreactor (Ambr, model AMBR24c) culture system 151 (TAP Biosystems, Cambridge, UK) ( Fig. 1A ) previously customized to be suitable for IC-152
BEVS expression experiments (Berger et al., 2013a (Berger et al., , 2013b . Importantly, a cooling element 153 was installed to operate at the temperatures relevant for insect cell production (26-27ºC). The 154
customized Ambr robot was placed in a tailor-made plastic containment for sterile operations. 155
The oxygen was provided by compressed and filtered air, supplied by a tubing connected to the 156 robot, avoiding costly pure air installation requirement. From the experimental design, 12 single 157 use bioreactors without sparger tubings were inoculated manually with 13 mL of Sf9 cultures 158 and the corresponding supplements (Fig 1) . Sf9 cells were inoculated at 0.5x10 6 cells.mL -1 , and 159
infected at approximately 1x10 6 cells.mL -1 with MOIs of 0.2, 1 and 5 IP.cell -1 . Each bioreactor 160 was equipped with dissolved oxygen (DO) and pH sensors, automatically recording and 161 monitoring each individual bioprocess. Culture agitation was performed by an 11.2 mm 162 impeller, set at 1400 rpm. In order to provide sufficient oxygen to the cultures, an additional air 163 input with a flowrate up to 0.9 mL/min was automatically provided to avoid the DO percentage 164 to drop below 40%. In practice, the latter never dropped below 70%. 165
To disclose specific requirements of each target in Sf9 host cell line, an extensive screening 166 in 100 mL Erlenmeyers (Corning, USA), with 10 mL working volume, was performed ( Fig.  167 1B). Sf9 cells were inoculated at 0.5x10 6 cells.mL -1 , kept at 27ºC and infected at 1x10 6 cells.mL -168 1 with MOIs of 0.2, 1 and 5 IP.cell -1 . Additionally, to evaluate if synergies between supplements 169 would occur, the combination of culture supplements was performed at this same scale, using a 170 MOI of 0.2 IP.cell -1 (Fig. 1C ). 171
The best culture condition leading to higher cell specific productivities of enveloped viral 172 particles was validated in a 0.5 L stirred tank bioreactor (BIOSTAT® QPlus, Sartorius AG, 173
Goettingen, Germany) ( Fig. 1D ). DO was set to 30% of air saturation and controlled by 174 sequential N 2 -stirring-O 2 cascade mode with 0.01 vvm gas flow rate. Temperature was kept at 175 27ºC and the operation was performed within a stirring range of 90-180 rpm. Sf9 cells were 176 inoculated at 0.5x10 6 cells.mL -1 and infected with BvHA5M1 at an MOI of 0.2 IP.cell -1 , 24 177 hours after inoculation. 178
For all culture settings ( Fig. 1A-D ), supplements were added in a two-times addition 179 mode, at inoculation, in order to precondition cells enabling an adaptation phase to their 180 addition, and at infection, to promote a productive cellular state, medium concentrations are 181 detailed in Table 1 . Non-supplemented cultures infected with the same set of MOIs were 182 performed as controls. Samples were collected every 24 hours and cell concentration and (hpi), the time after which the expression from polyhedrin and p10 promoters is maximal. In the 185 bioreactor cultures, enveloped viral particles production was followed throughout the entire 186 process (up to 96 hpi). 187
Influenza VLPs quantification 188
The quantification of the influenza VLPs (Inf-VLPs) was performed by solid phase 189 sandwich ELISA (SEK002, Sino Biological Inc., Beijing, China) specific for the hemagglutinin 190 (HA) displayed on the surface of the particles. The assay was done according to manufacturer 191 instructions, and HA-containing particles quantified in culture supernatant samples. 192
Product stability assays in supplemented media 193
Samples of BVs in culture media were incubated with the supplements at the same 194 concentration added to the cultures (Table 1) . Stability assays were performed at 27ºC during 48 195 hours, and supplement effect on baculovirus stability was evaluated by comparing virus 196 infectivity before and after incubation. Appropriate controls were performed, subjected to the 197 same incubation time in non-supplemented media. 198
Statistical analysis 199
Hypothesis testing was performed using Student's t-test. A 95% confidence interval was 200 considered to be statistically significant. 201 202 3. Results 203
Media manipulation strategies affect cell growth without compromising cell 204 viability and product stability 205
Ideally, medium supplements would improve cell productivity without compromising cell 206 growth and product stability. The effect of culture supplements on the growth rate of Sf9 cells is 207 presented in Table 2 . GSH, antioxidants, polyamines and biotin significantly decreased the 208 specific growth rate up to 2 fold, whereas cholesterol impaired cellular growth. Cell viability 209 was not compromised by the supplement addition (data not shown) and baculovirus stability 210
was not significantly affected ( Supplementary fig. 1 ). 211
Media manipulation strategies boost productivity of enveloped viral particles in 212

Sf9 cells 213
The exploratory screening using the Ambr culture system showed that baculovirus and Inf-214
VLPs yields increased (Supplementary Figure 2) in Sf9 cells following supplementation. These 215 results encouraged an extensive screening of the listed culture supplements (Table 1) and also 216 the evaluation of the supplementation impact on product quality. 217
The production of enveloped viral particles increased up to 3-fold by supplements with redox 218 balancing properties, mainly GSH, antioxidants and polyamines (Fig. 2 ). Although this set of 219 supplements decreased cell growth rate, their boost on cell specific productivity of infectious compared to control cultures ( Supplementary Table 1 ). Cholesterol supplementation boosted 222 both BVs and Inf-VLPs cell specific yields by 2.5 and 6-fold, respectively ( Fig. 2A and B) , 223 which is a noteworthy result given that cholesterol halted culture growth (Table 2 ). In general, 224 higher improvements on BVs production were achieved in infections performed with medium-225 high MOIs, yet for Inf-VLPs we could not trace a clear correlation between fold-change in the 226 production and MOI used (Fig. 2) . 227
Media manipulation strategies improve the quality of baculovirus particles 228 produced in Sf9 cells 229
The baculovirus used throughout this work is a difficult to produce virus, since relatively low 230 titers were reached upon virus stock preparation. Thus, this baculovirus is a good candidate to 231 test our proof-of-principle and test whether these supplements could also affect product quality. 232
To evaluate the effect of tested supplements on product quality we assessed the ratio of 233 infectious (IPs) to total particles (TPs). Viral quality was defined as a direct measure of 234 infectivity, meaning IPs generated. This analysis was performed in low MOIs infected cultures, 235 since those conditions are recommended for virus amplification towards higher viral stock 236
quality. 237
Polyamines and cholesterol yielded proportional improvements of both TPs and IPs, 238 resulting in similar TPs/IPs ratios ( Fig. 3, upper panel) . Importantly, GSH and antioxidants 239 combined with polyamines supplementation increased the IPs levels without altering TPs 240 formation (Fig. 3, bottom panel) . Therefore, these supplements improved final stock quality, as 241 demonstrated by the decrease in the TPs/IPs ratio ( Fig. 3, upper panel) . These results show that, 242 in addition to productivity, final product quality is also enhanced with the tested supplements. 243
Synergistic combination of supplements improve the production of enveloped 244 viral particles in Sf9 cells 245
The best supplements were combined in groups of metabolic related pathways, i.e. oxidative 246 stress and lipid metabolism and their impact on the specific productivity of Sf9 cells was 247 evaluated. The correlation between MOI and supplements impact on productivity was not 248 straightforward and depended on the target produced (Fig. 2 ). Since high MOI infections at 249 larger scales can be limiting and we are working with a challenging virus regarding infectious 250 particles titers, we decided to proceed with low MOI infections to analyze the synergies 251 between the supplements. Infections were performed at low MOI and the production of BVs and 252
Inf-VLPs assessed (Fig. 4) . The combination of cholesterol with polyamines boosted the 253 specific yields of BVs by 7-fold, twice the value obtained by the addition of cholesterol alone, 254 while no beneficial effect was observed in the Inf-VLPs specific yields by adding up 255 polyamines. 256 3.5. Implementation of an optimal bioprocess for the production of enveloped viral 257
particles in Sf9 cells via BEVS 258
The results obtained with cholesterol and polyamines supplementation were validated in 0.5 259 L stirred-tank bioreactors (Fig. 5 ). The addition of both supplements increased the production of 260 infectious BVs ( Fig. 5A ) and Inf-VLPs ( Fig. 5B ) compared to non-supplemented cultures. 261
Additionally, virus quality was also improved since the ratio between TPs and IPs was lower in 262 the supplemented cultures, and the virus amplification factor was enhanced by 6 fold (Table 3) . 263 264
Discussion
265
Several reports on IC-BEVS bioprocess optimization describe fed-batch strategies to 266 improve the production of recombinant proteins (Nguyen et al., 1993; Yang et al., 1996; Taticek 267 and Shuler, 1997; Chan et al., 1998; Palomares et al., 2004) or non-enveloped viral vectors ( Liu 268 et al., 2010; Mena et al., 2010) . Even though the IC-BEVS is massively used for the production 269 of VLPs (Liu et al., 2013) , and efforts have been made in understanding which are the process 270 parameters that contribute for better VLP yields (Cruz et al., 1998; Maranga et al., 2002; 271 Palomares et al., 2012; Pillay et al., 2009; Vieira et al., 2005) , reports on the identification of the 272 metabolic constraints in such targets production are still scarce. This is especially critical in the 273 case of enveloped viral particles produced via BEVS, challenging complex products with 274 stringent quality requirements not yet fully understood. In the present work, we analyzed the 275 impact of cell culture supplements in IC-BEVS productivity, focusing on enhancing quality and 276 titers of enveloped viral particles. The rationale behind this approach was provided by our 277 previous metabolomic characterization of the system, where metabolic pathways correlated with 278 baculovirus replication and productivity were identified (Monteiro et al., 2014 ). The 279 supplements tested were selected as boosters of these metabolic pathways, with the final goal of 280 driving cellular performance towards a higher productivity phenotype. 281
We observed that the addition of GSH, antioxidants and polyamines, increased cell specific 282 yields of infectious baculovirus particles. Baculovirus stock quality, i.e. infectivity, is 283 influenced by the metabolic state of the producer cell, as productivity and cellular metabolism 284 are correlated (reviewed in Aucoin et al., 2010). Among several roles in a cell, GSH is involved 285 in reactive oxygen species (ROS) detoxification and protein folding (Chakravarthi et al., 2006) . 286
Oxidative stress occurs as a consequence of baculovirus infection (Wang et al., 2001) , which 287 can be overcome by over-expressing the antioxidant enzyme manganese superoxide dismutase 288 thus precluding lipid and protein oxidation in baculovirus infected cells (Wang et al., 2004) . 289
Besides aiding in nucleic acids stabilization and transcription modulation, polyamines are able 290 to improve membrane rigidity, as well as preventing lipid peroxidation given their antioxidant 291
properties (Wallace et al., 2003) . The positive effect of polyamines on the production of 292 enveloped virus has been described (Raina et al., 1981; Rodrigues et al., 2013) . Replication of 293 baculovirus vectors is susceptible to the cellular metabolic state (Carinhas et al., 2010 (Carinhas et al., , 2009 , hypothesize that the joint action of polyamines and antioxidants, by empowering redox 296 homeostasis, can contribute to the observed improvements on baculovirus yields with increased 297 quality (i.e. infectivity). 298
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Supplemented culture (Cholesterol+Polyamines)
Control culture (non-supplemented) Time (hpi)  3  24  48  72  96  3  24  48  72  96 TP(10 2 .cell -1 ) 0.8 ± 0.08 1.6 ± 0.2 3 ± 0.3 2.8 ± 0.28 4 ± 0.4 1.9 ± 0.2 2.6 ± 0.3 4.4 ± 0.4 5.2 ± 0.5 8.6 ± 0.7 IP(10 -1 .cell -1 ) 0.8 ± 0.2 1.3 ± 0.4 3.2 ± 1 5.5 ± 2 6.9 ± 2 1.0 ± 0.3 0.8 ± 0.2 1.0 ± 0.3 1.6 ± 0.5 1.6 ± 0.5
Ratio TP/IP 1.1x10 3 1.3x10 3 9.1x10 2 5.1x10 2 5.7x10 2 1.9x10 3 3.2x10 3 4.4x10 3 3.2x10 3 5.3x10 3 AF a 7 18 69 128 124 10 7 8 21 26 
